Selected research
Industry Growth & Trends
Global Orexin Receptor Type 2 Industry Growth and Trends Forecast to 2032
Market perspective
According to APO Research, the global Orexin Receptor Type 2 market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Orexin Receptor Type 2 is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Orexin Receptor Type 2 is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Orexin Receptor Type 2 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global companies in the Orexin Receptor Type 2 market include Yangtze River Pharmaceutical Group, Eisai Co Ltd, Johnson & Johnson, Merck & Co Inc, OptiNose US Inc, Idorsia Ltd, Heptares Therapeutics Ltd, Evotec AG and Actelion Pharmaceuticals Ltd, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Orexin Receptor Type 2 market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Orexin Receptor Type 2 market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Orexin Receptor Type 2 market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Orexin Receptor Type 2.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global Orexin Receptor Type 2 market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Orexin Receptor Type 2 Market by Company
Yangtze River Pharmaceutical Group
Eisai Co Ltd
Johnson & Johnson
Merck & Co Inc
OptiNose US Inc
Idorsia Ltd
Heptares Therapeutics Ltd
Evotec AG
Actelion Pharmaceuticals Ltd
Orexin Receptor Type 2 Segment by Type
HTL-6641
MK-8133
OPN-021
YNT-185
Lemborexant
Others
Orexin Receptor Type 2 Segment by Application
Major Depressive Disorder
Sleep Disorders
Narcolepsy
Insomnia
Orexin Receptor Type 2 Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Orexin Receptor Type 2 market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Orexin Receptor Type 2 and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Orexin Receptor Type 2.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Orexin Receptor Type 2 companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- HTL-6641
- MK-8133
- OPN-021
- YNT-185
- Lemborexant
- Others
Applications
- Major Depressive Disorder
- Sleep Disorders
- Narcolepsy
- Insomnia
Companies covered
- Yangtze River Pharmaceutical Group
- Eisai Co Ltd
- Johnson & Johnson
- Merck & Co Inc
- OptiNose US Inc
- Idorsia Ltd
- Heptares Therapeutics Ltd
- Evotec AG
- Actelion Pharmaceuticals Ltd
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global Orexin Receptor Type 2 Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global Orexin Receptor Type 2 Market Size by Region (2021-2032)
- 1.4.1 Global Orexin Receptor Type 2 Market Size by Region (2021-2026)
- 1.4.2 Global Orexin Receptor Type 2 Market Size by Region (2027-2032)
- 1.5 Key Regions Orexin Receptor Type 2 Market Size (2021-2032)
- 1.5.1 North America Orexin Receptor Type 2 Market Size Growth Rate (2021-2032)
- 1.5.2 Europe Orexin Receptor Type 2 Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific Orexin Receptor Type 2 Market Size Growth Rate (2021-2032)
- 1.5.4 South America Orexin Receptor Type 2 Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa Orexin Receptor Type 2 Market Size Growth Rate (2021-2032)
2 Orexin Receptor Type 2 Market by Type
- 2.1 Type Introduction
- 2.1.1 HTL-6641
- 2.1.2 MK-8133
- 2.1.3 OPN-021
- 2.1.4 YNT-185
- 2.1.5 Lemborexant
- 2.1.6 Others
- 2.2 Global Orexin Receptor Type 2 Market Size by Type
- 2.2.1 Global Orexin Receptor Type 2 Market Size Overview by Type (2021-2032)
- 2.2.2 Global Orexin Receptor Type 2 Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global Orexin Receptor Type 2 Market Size Forecasted by Type (2027-2032)
- 2.3 Global Orexin Receptor Type 2 Market Size by Regions
- 2.3.1 North America Orexin Receptor Type 2 Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe Orexin Receptor Type 2 Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific Orexin Receptor Type 2 Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America Orexin Receptor Type 2 Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa Orexin Receptor Type 2 Market Size Breakdown by Type (2021-2026)
3 Orexin Receptor Type 2 Market by Application
- 3.1 Type Introduction
- 3.1.1 Major Depressive Disorder
- 3.1.2 Sleep Disorders
- 3.1.3 Narcolepsy
- 3.1.4 Insomnia
- 3.2 Global Orexin Receptor Type 2 Market Size by Application
- 3.2.1 Global Orexin Receptor Type 2 Market Size Overview by Application (2021-2032)
- 3.2.2 Global Orexin Receptor Type 2 Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global Orexin Receptor Type 2 Market Size Forecasted by Application (2027-2032)
- 3.3 Global Orexin Receptor Type 2 Market Size by Regions
- 3.3.1 North America Orexin Receptor Type 2 Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe Orexin Receptor Type 2 Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific Orexin Receptor Type 2 Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America Orexin Receptor Type 2 Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa Orexin Receptor Type 2 Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 Orexin Receptor Type 2 Industry Trends
- 4.2 Orexin Receptor Type 2 Industry Drivers
- 4.3 Orexin Receptor Type 2 Industry Opportunities and Challenges
- 4.4 Orexin Receptor Type 2 Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by Orexin Receptor Type 2 Revenue (2021-2026)
- 5.2 Global Orexin Receptor Type 2 Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global Orexin Receptor Type 2 Key Company Headquarters & Area Served
- 5.4 Global Orexin Receptor Type 2 Company, Product Type & Application
- 5.5 Global Orexin Receptor Type 2 Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global Orexin Receptor Type 2 Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 Orexin Receptor Type 2 Players Market Share by Revenue in 2025
- 5.6.3 2025 Orexin Receptor Type 2 Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 Yangtze River Pharmaceutical Group
- 6.1.1 Yangtze River Pharmaceutical Group Company Information
- 6.1.2 Yangtze River Pharmaceutical Group Business Overview
- 6.1.3 Yangtze River Pharmaceutical Group Orexin Receptor Type 2 Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 Yangtze River Pharmaceutical Group Orexin Receptor Type 2 Product Portfolio
- 6.1.5 Yangtze River Pharmaceutical Group Recent Developments
- 6.2 Eisai Co Ltd
- 6.2.1 Eisai Co Ltd Company Information
- 6.2.2 Eisai Co Ltd Business Overview
- 6.2.3 Eisai Co Ltd Orexin Receptor Type 2 Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 Eisai Co Ltd Orexin Receptor Type 2 Product Portfolio
- 6.2.5 Eisai Co Ltd Recent Developments
- 6.3 Johnson & Johnson
- 6.3.1 Johnson & Johnson Company Information
- 6.3.2 Johnson & Johnson Business Overview
- 6.3.3 Johnson & Johnson Orexin Receptor Type 2 Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 Johnson & Johnson Orexin Receptor Type 2 Product Portfolio
- 6.3.5 Johnson & Johnson Recent Developments
- 6.4 Merck & Co Inc
- 6.4.1 Merck & Co Inc Company Information
- 6.4.2 Merck & Co Inc Business Overview
- 6.4.3 Merck & Co Inc Orexin Receptor Type 2 Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 Merck & Co Inc Orexin Receptor Type 2 Product Portfolio
- 6.4.5 Merck & Co Inc Recent Developments
- 6.5 OptiNose US Inc
- 6.5.1 OptiNose US Inc Company Information
- 6.5.2 OptiNose US Inc Business Overview
- 6.5.3 OptiNose US Inc Orexin Receptor Type 2 Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 OptiNose US Inc Orexin Receptor Type 2 Product Portfolio
- 6.5.5 OptiNose US Inc Recent Developments
- 6.6 Idorsia Ltd
- 6.6.1 Idorsia Ltd Company Information
- 6.6.2 Idorsia Ltd Business Overview
- 6.6.3 Idorsia Ltd Orexin Receptor Type 2 Revenue, Global Share and Gross Margin (2021-2026)
- 6.6.4 Idorsia Ltd Orexin Receptor Type 2 Product Portfolio
- 6.6.5 Idorsia Ltd Recent Developments
- 6.7 Heptares Therapeutics Ltd
- 6.7.1 Heptares Therapeutics Ltd Company Information
- 6.7.2 Heptares Therapeutics Ltd Business Overview
- 6.7.3 Heptares Therapeutics Ltd Orexin Receptor Type 2 Revenue, Global Share and Gross Margin (2021-2026)
- 6.7.4 Heptares Therapeutics Ltd Orexin Receptor Type 2 Product Portfolio
- 6.7.5 Heptares Therapeutics Ltd Recent Developments
- 6.8 Evotec AG
- 6.8.1 Evotec AG Company Information
- 6.8.2 Evotec AG Business Overview
- 6.8.3 Evotec AG Orexin Receptor Type 2 Revenue, Global Share and Gross Margin (2021-2026)
- 6.8.4 Evotec AG Orexin Receptor Type 2 Product Portfolio
- 6.8.5 Evotec AG Recent Developments
- 6.9 Actelion Pharmaceuticals Ltd
- 6.9.1 Actelion Pharmaceuticals Ltd Company Information
- 6.9.2 Actelion Pharmaceuticals Ltd Business Overview
- 6.9.3 Actelion Pharmaceuticals Ltd Orexin Receptor Type 2 Revenue, Global Share and Gross Margin (2021-2026)
- 6.9.4 Actelion Pharmaceuticals Ltd Orexin Receptor Type 2 Product Portfolio
- 6.9.5 Actelion Pharmaceuticals Ltd Recent Developments
7 North America
- 7.1 North America Orexin Receptor Type 2 Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America Orexin Receptor Type 2 Market Size by Country (2021-2026)
- 7.3 North America Orexin Receptor Type 2 Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe Orexin Receptor Type 2 Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe Orexin Receptor Type 2 Market Size by Country (2021-2026)
- 8.3 Europe Orexin Receptor Type 2 Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Orexin Receptor Type 2 Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific Orexin Receptor Type 2 Market Size by Country (2021-2026)
- 9.3 Asia-Pacific Orexin Receptor Type 2 Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America Orexin Receptor Type 2 Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America Orexin Receptor Type 2 Market Size by Country (2021-2026)
- 10.3 South America Orexin Receptor Type 2 Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Orexin Receptor Type 2 Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa Orexin Receptor Type 2 Market Size by Country (2021-2026)
- 11.3 Middle East & Africa Orexin Receptor Type 2 Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst